Trends in Medicines Discontinuation and Implications for Access in Brazil (2014–2024)
Pharmacoepidemiology and Drug Safety · 2026-09 · 35 (9)
DOI: 10.1002/pds.70458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 22.08.2026. Verfasst von Raphaella Oliveira Martins de Lima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro Multidisciplinar UFRJ/Macaé, Federal University of Rio de Janeiro, Macaé, Brazil. Hauptthemen laut MEDLINE: Drugs, Essential, Drugs, Generic, Health Services Accessibility. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The World Health Organization ( WHO ) began recognizing drug shortages as a global issue in 2014, impacting health systems and patient care. Shortages arise from supply chain disruptions, production issues, and mismatches between supply and demand, aggravated by insufficient mechanisms for forecasting and communication.
Methods
The study analyzed medicine discontinuation notifications in Brazil from 2014 to 2024 from a public secondary database. Data was downloaded, organized, and cleaned using Excel, incorporating ATC classification and verification of medicines listed on the National Essential Medicines List ( NEML / RENAME ). Statistical analyses included descriptive statistics and association tests (Pearson's χ 2 , Fisher's exact test) examining discontinuation types, registration categories, reasons, and NEML presence.
Results
Between 2014 and 2024, Brazil had 23, 110 discontinuation notifications, of which 15, 599 (67.5%) were temporary, and 7,511 (32.5%) were definitive discontinuation. The annual distribution was not homogeneous. Generic had the highest proportion of discontinuations (37.2%), surpassing branded generics (33.2%) and originator brands (15.9%). In contrast, biological products, herbal medicines, dynamized medicines, and specific medicines together accounted for only 13.73% of the total. Regarding the reasons for discontinuation, commercial reasons predominated, accounting for 73.4% of notifications. Finally, it was found that the majority of discontinued drugs were not included in NEML (73.9%).
Conclusions
Medicine discontinuation in Brazil from 2014 to 2024 is mainly temporary and occurs for generics and branded‐generics due to commercial decisions. The findings highlight the complexity of supply continuity and the importance of strategies that include diversifying supply sources, strengthening regulatory oversight, and improving monitoring and communication systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro Multidisciplinar UFRJ/Macaé, Federal University of Rio de Janeiro, Macaé, Brazil.
- Division of Thoracic Surgery, Department of Surgery, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
- Centro Multidisciplinar UFRJ/Macaé, Núcleo de Avaliação de Tecnologia em Saúde-Gestão, Economia, Educação em Saúde e Serviços Farmacêuticos (GEESFAR/NATS/UFRJ), Federal University of Rio de Janeiro, Rio de Janeiro, Braz…
- Laboratório e Observatório em Vigilância & Epidemiologia Social, Universidade Federal do Sul e Sudeste do Pará (LOVES/Unifesspa), Pará, Brazil.
ORCID-Profile: Raphaella Oliveira Martins de Lima, Esther Ramos Silva, Isabel C M Emmerick, Danielle Maria de Souza Serio Dos Santos, Isabella Piassi Dias Godói, Ana Cristina Viana Campos, Luisa Arueira Chaves
Zitieren
APA
de Lima, R. O. M., Silva, E. R., Emmerick, I. C. M., de Souza Serio Dos Santos, D. M., Godói, I. P. D., Campos, A. C. V., & Chaves, L. A. (2026). Trends in Medicines Discontinuation and Implications for Access in Brazil (2014–2024). Pharmacoepidemiology and Drug Safety, 35(9). https://doi.org/10.1002/pds.70458
Vancouver
de Lima ROM, Silva ER, Emmerick ICM, de Souza Serio Dos Santos DM, Godói IPD, Campos ACV, et al. Trends in Medicines Discontinuation and Implications for Access in Brazil (2014–2024). Pharmacoepidemiology and Drug Safety. 2026;35(9). doi:10.1002/pds.70458
BibTeX
@article{deLima2026,
author = {de Lima, Raphaella Oliveira Martins and Silva, Esther Ramos and Emmerick, Isabel C M and de Souza Serio Dos Santos, Danielle Maria and Godói, Isabella Piassi Dias and Campos, Ana Cristina Viana and Chaves, Luisa Arueira},
title = {Trends in Medicines Discontinuation and Implications for Access in Brazil (2014–2024)},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
volume = {35},
number = {9},
doi = {10.1002/pds.70458}
}
EUVIMED